Organization
CHU de Nice
3 abstracts
Abstract
When to stop immunotherapy for advanced melanoma: Emulation of target trials.Org: Université Paris Cité et INSERM, CHRU Lille - Hôpital Claude Huriez, Rhône-Alpes, CHU de Dijon, CHU Albert Michallon,
Abstract
Nivolumab combined with high dose multisite radiotherapy in previously untreated advanced melanoma (NIRVANA): A non-randomised, open-label, multicenter, phase 2 trial.Org: Dermatology Department, Université Côte d'Azur, CHU de Nice, Nice, France,
Abstract
Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: PAZOGLIO trial.Org: Centre Antoine-Lacassagne, University Côte d'Azur, ICO Cancer Center, Institut de Cancérologie de l’Ouest, CHU de Nice,